Atomwise Blog

June 27, 2022
AI Technology, AI Drug Discovery

Our scientists have developed a set of chemical benchmarks to better understand exactly what our computational models are learning. At Atomwise, AtomNet® structure-based models can quickly identify active compounds for protein targets from large […]

Read Article
March 09, 2022
Events, ACS2022

At the American Chemical Society Spring National Meeting & Expo, Atomwise members were selected to present their research and work. Learn what our Atoms have been working on below and visit Atomwise at ACS Spring 2022 National Meeting for other […]

Read Article
February 28, 2022
AI Technology, AI Drug Discovery

 Atomwise scientists are adapting machine learning models to make predictions about a class of drug compounds that has been challenging to study.

Read Article
February 24, 2022
Events, ACS2022

At the American Chemical Society Spring National Meeting & Expo, Atomwise members were selected to present their research and work. Learn what our Atoms have been working on below and visit Atomwise at ACS Spring 2022 National Meeting for other […]

Read Article
February 24, 2022
Events, ACS2022

At the American Chemical Society Spring National Meeting & Expo, Atomwise members were selected to present their research and work. Learn what our Atoms have been working on below and visit Atomwise at ACS Spring 2022 National Meeting for other […]

Read Article
February 24, 2022
Events, ACS2022

At the American Chemical Society Spring National Meeting & Expo, Atomwise members were selected to present their research and work. Learn what our Atoms have been working on below and visit Atomwise at ACS Spring 2022 National Meeting for other […]

Read Article
January 25, 2022
AI Technology, AtomNet, AI Drug Discovery

Our researchers are developing an automated pipeline that can more accurately identify promising compounds targeting multi-site proteins

Read Article
January 24, 2022
AI Technology, AtomNet

Atomwise scientists are improving predictive models for ADMET profiling by including a pre-training step that builds on diverse publicly available datasets

Read Article
November 23, 2021
AIMS, Academic Research

Until recently, a diagnosis of sickle cell disease was considered a death sentence. Now, people with this blood disorder are more likely to live well into adulthood, but they still suffer from severe bouts of pain and an increased risk of infection.

Read Article
Pages: 1 2 3 4 5 ... 8 »

Subscribe

Stay up to date on new blog posts.

Atomwise needs the contact information you provide to send you updates. You may unsubscribe from these communications at any time. For information please review our Privacy Policy.